Heart rate (HR) assessed by electrocardiogram (ECG-HR) and pulse rate (PR) measured in a physician's office (office-PR) are taken with subjects in different body positions-i.e., supine vs. sitting. Although analysis of HR differences according to body position could provide new practical insights, there have been few studies on the subject. We herein investigated whether the difference between office-PR and ECG-HR (delta HR) was associated with brain natriuretic peptide (BNP) levels and left ventricular mass (LVM).
Original article
Heart rate (HR) is one of the easiest biomarkers to obtain and requires no special techniques. Increased HR has been associated with cardiovascular events both in the general population and in individuals with cardiovascular risk factors. [1] [2] [3] [4] [5] [6] [7] [8] In patients with heart failure in particular, HR has been accepted as not only a prognostic marker but also a potential therapeutic target in the chronic phase. 9 Although the results of HR measurement must take into consideration the measurement setting, i.e., pulse rate (PR) in a physician's office (office-PR) vs. HR assessed by electrocardiogram (ECG-HR), no clear practical difference has been established between these 2 measures despite their differences in body position-i.e., the sitting and supine positions, respectively. 10 In addition, although analyzing the differences in HR according to body position might be expected to provide new practical insights, few studies have addressed this subject. In one of the few exceptions, Maeder et al. found that a small HR increase upon changing from a supine to upright position was a prognostic marker for heart failure hospitalization in a population of chronic heart failure patients with symptoms. 11 These findings raise the possibility that changes in HR according to body posture may be associated with a surrogate marker of heart failure in the subclinical heart failure population.
Brain natriuretic peptide (BNP) levels and left ventricular mass (LVM) have been well acknowledged to be surrogate markers of not only cardiac overload but also the development of heart failure. 12, 13 Therefore, we hypothesized that the difference in office-PR measured in a sitting position and ECG-HR measured in a supine position (delta HR) may be associated with BNP and LVM in individuals with subclinical heart failure.
To test this hypothesis, we used data from the Japan Morning Surge-Home Blood Pressure (J-HOP) study, which consisted of a large sample of asymptomatic patients with 1 or more cardiovascular risk factors, to investigate the association between the delta HR and either BNP or LVM.
METHODS

Study subjects
The participants of this study were from the J-HOP study, which is an observational study of home blood pressure (BP) measurement in a clinical population. The protocol of the J-HOP study was approved by the Ethics Committee of the Internal Review Board of the Jichi Medical University School of Medicine, Tochigi, Japan. The protocol of the J-HOP study was registered on a clinical trials registration site (University Hospital Medical Information Network-Clinical Trials Registry (UMIN-CTR): #UMIN000000894). Written informed consent was obtained from all patients who enrolled in the study. The details of the J-HOP study have been reported elsewhere. 14 Between January 2005 and May 2012, the J-HOP study enrolled 4,310 ambulatory patients who had one or more of the following cardiovascular risks: hypertension, hyperlipidemia, diabetes (fasting glucose 126 mg/dl and/or receiving an antidiabetic drug), glucose intolerance, metabolic syndrome, chronic kidney disease (estimated glomerular filtration rate <60 ml/min/1.73 m 2 ), history of cardiovascular disease (CVD-coronary artery disease, stroke, aortic dissection, peripheral artery disease, and/or congestive heart failure), atrial fibrillation, current smoking, chronic obstructive pulmonary disease, and sleep apnea syndrome. Of these 4,310 participants, we excluded individuals without data of ECG (n = 592), those with atrial fibrillation (n = 161), and those treated with a β-blocker (n = 590). Thus, 2,972 participants were included in the final analysis in this study.
In the present study, diabetes was defined as a fasting glucose level ≥126 mg/dl, a glycated hemoglobin level ≥6.1% and/or treated diabetes. Hypertension was defined as clinical systolic BP (SBP) of at least 140 mm Hg, diastolic BP (DBP) of at least 90 mm Hg, and/or use of an antihypertensive medication. CVD was defined as prior angina pectoris, myocardial infarction, and/or stroke. Blood examination, ECG, and echocardiography were performed within 3 months after the initial office visit at which BP was measured for this study.
Office BP and PR measurements
Office BP and PR were measured in a sitting position using a validated upper arm cuff oscillometric BP device (HEM-5001; Medinote, Omron Healthcare, Kyoto, Japan) 15 according to the Japanese Society of Hypertension 2004 guidelines. 16 This device automatically takes 3 measurements at 15-second intervals after a measurement button is pressed once. All recorded BP and PR values were stored along with the time information. The office BP and PR values for this analysis were obtained using an average of 6 readings from 2 clinic visits by each patient. The patients were instructed to take their morning medication as usual on the days when they visited the office.
ECG measurement and interpretation
ECGs were obtained at a paper speed of 25 mm/s and a gain of 10 mm/mV (or 5 mm/mV) using the ECG devices at the participating institutes. Then, at a central laboratory, 2 trained individuals who did not know the subjects' backgrounds assessed the ECG parameters using a ruler with 0.01-mm gradations. R-R intervals were measured, and the mean of 3 R-R intervals was calculated.
Echocardiographic measurements
Echocardiography was performed at each participating institute. Two-dimensional M-mode or B-mode images were obtained using an ultrasound machine according to the guidelines of the American Society of Echocardiology and the European Association of Echocardiography. 17 
Blood examinations
Blood samples were collected in the morning upon the patient's arrival at the hospital in a fasting state. Samples were collected twice, once at enrollment and once at the end of the study. The blood samples were centrifuged at 3,000g for 15 minutes at room temperature. Plasma/serum samples after separation and urine samples were stored at 4 °C in refrigerated containers and sent to a commercial laboratory (SRL, Tokyo, Japan) within 24 hours. All assays were performed within the next 24 hours at this single laboratory center. The plasma BNP level was determined using a highsensitivity, noncompetitive radioimmunoassay (ShionoRIA BNP; Shionogi, Osaka, Japan) (SRL).
Statistical analyses
All analyses were performed in each of the 2,972 patients. Because the distribution of the plasma BNP levels was highly skewed, it was log-transformed before the statistical analysis and expressed as the geometric mean ± SD. The χ 2 test was used to detect differences in the prevalence rate among groups. One-way analysis of variance was performed to detect differences in continuous variables of baseline characteristics among quintiles of delta HR. Analysis of covariance was performed to detect the relationship of BNP and LVMI to each quintiles of delta HR after adjustment for acknowledged cardiovascular risk factors (age, gender, body mass index, total cholesterol, high-density lipoprotein cholesterol, current smoking, diabetes, treated hypertension and past history of CVD, and office SBP) and ECG-HR, and the Bonferroni test was used for multiple pairwise comparisons. Next, we substituted pulse pressure for SBP as a covariate, given that HR was more strongly associated with pulse pressure than SBP. 18 Pearson's correlation was performed for the association between patient demographics and ECG-HR or office-PR. Multiple linear regression analysis was performed to assess the association between the delta HR and either BNP or LVMI after adjustment for covariates. We also substituted pulse pressure for SBP as a covariate in this analysis. Associations/differences with a P value <0.05 (2-tailed) were considered to be statistically significant. All statistical analyses were performed with IBM SPSS Statistics version 22 software (SPSS, Chicago, IL).
RESULTS
Patients' characteristics
The baseline characteristics are shown in Table 1 . Average age was 64.3 ± 10.8 years and the prevalence of males was 45%. The average values of office-PR and ECG-HR were 72.1 ± 10.3 bpm and 66.6 ± 11.9 bpm, respectively. Office-PR was significantly higher than ECG-HR (P < 0.001) and was correlated with ECG-HR (r = 0.64, P < 0.001). There was no heterogeneity of the association between patient's demographics and ECG-HR or office-PR excluded for office SBP and pulse pressure ( Table 2) . Table 3 shows the patients' characteristics according to quintile categories of the delta HR. Age, SBP, and pulse pressure were incrementally lower in each quintile in order from lowest to highest. In contrast, DBP was incrementally higher in each quintile in order from lowest to highest. Office-PR increased incrementally, while ECG-HR decreased incrementally in each quintile in order from lowest to highest. There were no differences in the other patient characteristics among quintiles. Figure 1 shows the BNP and LVMI according to quintile categories of delta HR. After adjustment for age, sex, body mass index, total cholesterol, high-density lipoprotein cholesterol, current smoking, diabetes, office SBP, ECG-HR, treated hypertension, and past history of CVD, BNP and LVMI incrementally decreased with quintile from the lowest to highest (Table 4 ). When we substituted pulse pressure for SBP as a covariate, these associations remained (Supplementary Table S1 ). Finally, when we analyzed dependent variables as continuous values, multiple linear regression analysis showed that the delta HR was independently and significantly associated with both log-transformed BNP (β = −0.179, P < 0.001) and LVMI (β = −0.113, P = 0.001) after adjustment for age, sex, body mass index, total cholesterol, high-density lipoprotein cholesterol, current smoking, diabetes, office SBP, ECG-HR, treated hypertension, and past history of CVD. Even when we substituted pulse pressure for SBP as a covariate, the delta HR was independently and significantly associated with both log-transformed BNP (β = −0.156, P < 0.001) and LVMI (β = −0.081, P = 0.017). Data are the mean ± SD or median (25%, 75%) or a percentage. Abbreviations: BNP, brain natriuretic peptide; CVD, cardiovascular disease; DBP, diastolic blood pressure; ECG-HR, heart rate assessed by electrocardiogram; LVMI, left ventricular mass index; PR, pulse rate; SBP, systolic blood pressure. 
Association between delta HR and cardiac overload
Association between ECG-HR or office-PR and cardiac overload
When we divided patients into quintiles according to ECG-HR, the BNP value incrementally decreased with quintile from the lowest to highest ( Table S2 ). When we substituted pulse pressure for SBP as a covariate, these associations remained (data not shown).
DISCUSSION
The present study showed that decreased delta HR was positively associated with BNP level and LVMI. In general, physiological HR in normal subjects is lower in a supine position than a sitting position. 9 There has been only one previous report in which the degree of change in HR from the supine to the upright position was an independent prognostic predictor of death or heart failure hospitalization in elderly patients with congestive heart failure. 11 The novelty of our study was its evaluation of the association between postural HR change and BNP and LVMI as a surrogate marker of the development of heart failure in a population without heart failure. Therefore, this study adds further evidence to support the thesis that the degree of change in HR according Data are the mean ± SD or a percentage. Delta HR is defined as upright HR (office-PR) − supine HR (ECG-HR). Abbreviations: CVD, cardiovascular disease; DBP, diastolic blood pressure; ECG-HR, heart rate assessed by electrocardiogram; HDL, high-density lipoprotein; PR, pulse rate; SBP, systolic blood pressure.
to body posture is a clinical sign associated with subclinical and clinical heart failure.
Although a high BNP level has been shown to be an independent predictor of not only heart failure occurrence or mortality but also cardiovascular events or mortality both in the general and the cardiovascular population, another study showed that LVMI was a more powerful predictor of cardiovascular events than BNP in both these populations. [19] [20] [21] [22] In a prior analysis, a 10 g/m 2 difference in LVMI in hypertensive patients was associated with a 10% increased cardiovascular risk. 19 In our present study, the lowest delta HR quintile group had an approximately 10 g/m 2 higher LVMI than the highest quintile group. Using the index of our findings might provide the difference of 10% increased cardiovascular risk between the lowest and highest cardiovascular risk groups. In addition, only patients with 1 or more cardiovascular risk factors who were almost classified as Stage A heart failure patients were eligible for this study, and these patients were at high risk of developing advanced heart failure based on the international guidelines. 23 Decreased delta HR might be a cardiovascular risk in the population with potential development of heart failure.
The results of this study did not clarify the detailed mechanism underlying the association between decreased delta HR and increases in either BNP or LVMI. However, we can speculate the following in regard to this mechanism. First, in normal subjects, a physiological HR response to postural change is observed-i.e., the HR is lower in the supine than the sitting position. This change is caused by the displacement of roughly 400-800 ml of blood volume between the heart and abdomen or extremities. The Bainbridge reflex is known to be a positive feedback mechanism in which there is a compensatory increase in HR due to a rise in right atrial pressure induced by volume overload. 24 However, under normal conditions, the increased aortic pressure induced by volume overload also activates the baroreceptor reflex, which leads to decreased HR. Therefore, in normal subjects, the physiological HR response to a change in body position remains. However, patients with cardiovascular risk are known to exhibit an impaired baroreceptor reflex. 25 Therefore, in the current population of subjects with subclinical heart failure, the balance between the Bainbridge and baroreceptor reflexes may have been disrupted, resulting in an abnormal HR response to the change from a sitting to supine position. Second, fluid retention due to venous return from peripheral vessels occurs upon the change from standing or sitting to a supine position, which would cause cardiac overload but maintain the hemodynamic balance without an increase in HR due to the maintenance of cardiac autonomic function. Patients with LV dysfunction or LV hypertrophy are often complicated with cardiac autonomic dysfunction, [26] [27] [28] which may cause an abnormal HR response to postural change. However, the directional nature Data are means (95% confidence interval). Analysis of covariance adjusted for age, sex, body mass index, total cholesterol, high-density lipoprotein cholesterol, current smoking, diabetes, office systolic blood pressure, ECG-HR, treated hypertension, and past history of cardiovascular disease was used. Delta HR is defined as upright HR (office-PR) − supine HR (ECG-HR). Abbreviations: BNP, brain natriuretic peptide; ECG-HR, heart rate assessed by electrocardiogram; LVMI, left ventricular mass index.
of the cause-and-effect relationship between the HR change and increased BNP and LVMI as subclinical heart failure was not clarified in the present study.
In our study, when we divided patients into quintiles based on ECG-HR, BNP or LVMI appeared to decrease incrementally with quintile from the lowest quintile to the highest quintile after adjustment for covariates. Increased HR has been associated with cardiovascular events both in the general population and in populations with cardiovascular risk. [1] [2] [3] [4] [5] [6] [7] [8] The MESA (Multi-Ethnic Study of Atherosclerosis) trial, which included both a cross-sectional analysis between HR and LVMI and a prospective analysis between HR and cardiovascular events, showed that increased HR was a predictor of worse prognosis but was associated with lower LVMI. 29 Thus, HR change appears to have a different impact on cardiovascular prognosis and LVMI. However, the association between HR and LVMI is likely to be a physiological phenomenon. In subjects without heart failure, decreased HR causes an amplification of stroke volume and LV end-diastolic pressure to maintain cardiac output, i.e., the Frank-Staring curve. Increased LV end-diastolic pressure is known to be strongly associated with LVM. 30 Longterm exposure to increased HR may be not only a marker of increased sympathetic nerve activity 31 but also an independent factor promoting atherosclerosis. Other previous reports have shown that cyclic stretch stimulates superoxide production, 32 vascular fibronectin gene expression, 33 collagen synthesis, 34 and growth factor 35 in vascular smooth muscle. Therefore, increased HR might be associated with worse cardiovascular prognosis via specific vascular organ damage over time.
Limitations
Firstly, our data do not allow us to determine the causal relationship because this is a cross-sectional study. Secondly, ECG-HR and office-PR were measured under different situations. There were variations in the duration of rest before measurement, environmental conditions, measurement methods, and nature of the observer. Moreover, there was a long interval between these 2 measurements (weeks to months). Further studies will thus be needed to test our results using similar conditions for both the ECG-HR and office-PR measurements. Third, some medications may have affected our findings, although we excluded the patients' prescribed β-blockers, which have the greatest influence on HR. Further prospective studies will be needed to clarify the association between the delta HR and cardiovascular events. Finally, although we speculated that decreased delta HR may be closely related to impaired baroreflex sensitivity or an autonomic nerve imbalance, we did not assess reliable parameters for autonomic nervous system function.
In conclusion, decreased delta HR was positively associated with BNP and LVMI. This evaluation, which requires no special technique, might indicate potential cardiac overload and thus provide a clinical sign related to heart failure.
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